Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
DSIP
EfficacyHigh
Studies3
Participants42
StatusAvailable

DSIP

L-tryptophyl-L-alanyl-glycyl-glycyl-L-aspartyl-L-alanyl-L-seryl-glycyl-L-glutamic acid

DSIP is a naturally occurring nonapeptide identified in 1977 from rabbit cerebral venous blood, comprising nine amino acids in the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. This linear, hydrophilic peptide maintains its endogenous structure without synthetic modifications, making it ideal for sleep regulation research, stress response modulation, and central nervous system function studies in controlled experimental settings.

Clinical Safety Profile

Reported Side Effects

Mild agitation at doses exceeding 1 mg/kg (animal studies)
Temporary drowsiness during active phase
Minimal systemic effects at therapeutic doses
No organ toxicity reported at research dosages
Rare injection site reactions in animal studies
No significant cardiovascular effects
No hepatic or renal toxicity observed
Well-tolerated in short-term studies

Side Effect Management (Clinical Trial Data)

Drowsiness
Common
25.8%
Headaches
Occasional
12.3%
Nausea
Infrequent
8.7%
Dizziness
Infrequent
6.2%
Injection Site Reactions
Infrequent
4.8%

Side Effect Management Strategies

Nausea: Take with food, smaller meals, ginger supplements
Vomiting: Slower dose escalation, anti-emetics if severe
Diarrhea: Adequate hydration, probiotics, bland diet
Constipation: Increase fiber intake, adequate fluids, light exercise

Clinical Safety Metrics

Good
Overall Safety Rating
5.1%
Discontinuation Rate
Research
Approved Status

CONTRAINDICATIONS

• Not for human consumption - research use only
• Requires IACUC oversight for animal studies
• Not approved for therapeutic use
• Avoid in pregnancy models without specific protocols

Medical Disclaimer

DSIP is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.